Thymosin Alpha-1 (T1) is an immune-modulating peptide that enhances T-cell function, upregulates MHC expression, and rebalances the Th1/Th2 response used for immune support and post-viral recovery
Tc v mng chc khe: Tc chc khe hn, mng t b gy rng
Han M, Jeong S, Song J, Park SJ, Min Lee C, Lee K, et al
[10] Gastrointestinal disturbances-including nausea, loose stools, and a transient fishy body-odor attributable to trimethylamine production from excessive carnitine and choline metabolism-occur in a minority of recipients and are usually self-limiting within 24 to 48 hours after injection
Dosing and Administration BPC-157 is most often administered via subcutaneous injection with a small-gauge needle, typically once daily
2019;8(Suppl 1):S36